Table 2.1: Generic market share of total retail pharmaceutical market
Table 3.1: Overall health system performance of selected countries, 1997
Table 3.2: Public expenditure on health as % GDP
Table 3.3: Public expenditure on pharmaceutical goods as a % of public health expenditure
Table 3.4: Examples of pharmaceutical trade control mechanisms used in the EU
Table 3.5: National pharmaceutical markets, 1998 (ex-factory prices)
Table 3.6: Investment in pharmaceutical R&D, 1998
Table 4.1: Differing national status of pharmacy chains
Table 4.2: Uptake of electronic communications between wholesaler and pharmacy in selected countries, 1999
Table 6.1: Number of pharmaceutical companies operating in Europe and pharmaceutical production, 1998
Table 6.2: European market in community and hospital pharmacies and other outlets, 1998 (Euro m, at ex-factory prices)
Table 6.3: European medicines market per head of population (1998)
Table 6.4: Payment for medicines by compulsory health insurance systems and national health services (1998)
Table 6.5: European medicines market, 1998
Table 8.1: Sales of generic medicines, 1997
Table 9.1: National pharmacy qualifications and length of study
Table 9.2: Proportion of teaching time given to individual subject areas in the EU member states (1995)
Table 9.3: The Netherlands: number of pharmacists by gender, 1999
Table 9.4: Number of Apoteket employees by gender, Sweden 1999
Table 9.5: Research priorities reported by national pharmacy associations
Table 10.1: Numbers of pharmacies, pharmacists and support staff 1997-2000